James Investment Research’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-5,068
Closed -$317K – 329
2024
Q1
$317K Buy
5,068
+2
+0% +$136 0.04% 258
2023
Q4
$379K Sell
5,066
-566
-10% -$40.5K 0.05% 227
2023
Q3
$480K Sell
5,632
-5,234
-48% -$496K 0.06% 197
2023
Q2
$1.19M Sell
10,866
-178
-2% -$16.9K 0.15% 122
2023
Q1
$916K Sell
11,044
-223
-2% -$21K 0.12% 137
2022
Q4
$1.16M Sell
11,267
-739
-6% -$85.1K 0.16% 118
2022
Q3
$1.27M Buy
12,006
+6,803
+131% +$746K 0.18% 117
2022
Q2
$571K Sell
5,203
-2,508
-33% -$248K 0.08% 172
2022
Q1
$804K Buy
7,711
+4,545
+144% +$472K 0.08% 161
2021
Q4
$387K Buy
3,166
+730
+30% +$81K 0.04% 228
2021
Q3
$280K Buy
2,436
+666
+38% +$70.6K 0.03% 240
2021
Q2
$172K Buy
1,770
+904
+104% +$78.4K 0.01% 303
2021
Q1
$64K Sell
866
-32
-4% -$2.38K 0.01% 361
2020
Q4
$61K Buy
+898
New +$58.5K 0.01% 363
2019
Q2
– Sell
-1,230
Closed -$58K – 674
2019
Q1
$58K Buy
+1,230
New +$68.2K ﹤0.01% 633
2018
Q3
– Sell
-36,325
Closed -$2.13M – 784
2018
Q2
$2.13M Buy
+36,325
New +$2.17M 0.08% 300
2018
Q1
– Sell
-40,200
Closed -$1.98M – 779
2017
Q4
$1.98M Buy
+40,200
New +$1.83M 0.07% 286

Other funds holding AMN

James Investment Research's AMN Position: Q2 2024 in Review

James Investment Research sold out of AMN Healthcare (AMN) in Q2 2024, closing a stake of 5,068 shares — an estimated $317K sold.

James Investment Research first reported a position in AMN in Q4 2017 and held it in 17 quarters. The position peaked at $2.13M in Q2 2018. 328 funds tracked by Wall St. Rank hold AMN as of Q2 2024.

  • James Investment Research reported no remaining AMN Healthcare position as of Q2 2024 after selling out during the quarter.
  • James Investment Research sold 5,068 AMN Healthcare shares in Q2 2024, an estimated $317K.
  • James Investment Research first reported a position in AMN Healthcare in Q4 2017 and held it in 17 quarters.
  • James Investment Research's AMN Healthcare position peaked at $2.13M in Q2 2018.
  • 328 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2024.

Based on James Investment Research's 13F filing for Q2 2024, filed 30 Jul 2024.